0       0

AMDA's 31st Annual Symposium


A02 - Clinical Controversies: Statin Island: How Low Should it Go?; PPIs Forever?; Alzheimer's Disease: To Treat or Not to Treat


Mar 6, 2008 8:00am ‐ Mar 6, 2008 11:30am

Standard: $20.00

Description

This session addresses 3 controversial topics; Statin use, PPI use, and Alzheimer’s Disease agent use in elderly LTC patients. The following questions will be addressed: Are high dose statins necessary in the elderly? Do PPI's pose any problems, especially with long term use? What should be considered in long term use of PPIs? Is there enough data to support the use of Alzheimer Disease agents currently available and the duration of their use? The format will be an exciting point-counter point debate of these controversial issues in long term care medicine and pharmacy. For each topic, there will be a brief didactic presentation setting up the issues and controversies followed by a crossfire-like debate between panelists representing the pro and con for the topic.

    Learning Objectives:
  • Summarize the evidence for and against intensive lipid lowering therapy in the elderly LTC population
  • Discuss the evidence for and against long term PPI therapy for various indications in the elderly LTC population
  • Summarize the evidence for and against the use of the currently available Alzheimer's Disease agents in the elderly LTC population

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content